… In summary, pemetrexed has emerged as a promising new … combinations has remained
almost purely empirical,1, 2 and anticancer drug combinations in non–small cell lung cancer (…

… Thus, the pemetrexed–platinum backbone provides an attractive option for combination with
… of pemetrexed–platinum as a backbone for combination with targeted therapies for NSCLC. …

… of advanced non-small cell lung cancer (NSCLC), the … cytotoxic agent, pemetrexed, and its
combination with platinums … ) to pemetrexed/platinum in NSCLC, and the role of pemetrexed/…

… pemetrexed and its activity against a wide range of solid tumors.7 Another early Phase I
study established the safety of pemetrexed in combination … from Australia, pemetrexed as first-…

… of pemetrexed in … of lung cancer, allowing physicians to tailor therapies to the individual
patient. Ongoing trials aim to establish the place of pemetrexed in maintenance, in combination …

… Pemetrexed, a novel multi-targeted agent established for the treatment of mesothelioma, …
-cell lung cancer (NSCLC). In the present trial we investigated pemetrexed in combination with …

… Inthisreport,wecomparetheefectsandtoxicities in advanced NSCLC patients treated with
pemetrexed monotherapyversuspemetrexedplusplatinum combination agentso as co provide a …

… The primary objective of the current combined analysis of three large phase 3 trials was
to determine the comparability (overall and by histology) of pemetrexed–cisplatin with other …

… Adjei, AA Gemcitabine and pemetrexed disodium combinations in vitro and in vivo Lung
Cancer … Dark, GG Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in …

… the purpose of investigating the possible advantage of combining pemetrexed with other
agents. Combinations of pemetrexed and cisplatin or carboplatin in previously treated NSCLC …